Silvius Stanciu | Biology and Life Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Silvius Stanciu
“Dunarea de Jos” University of Galati, Romania

Silvius Stanciu
Affiliation “Dunarea de Jos” University of Galati
Country Romania
Scopus ID 57202534648
Documents 118
Citations 639
h-index 13
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-7697-0968

The Innovative Research Award recognizes scholarly achievement and interdisciplinary scientific contribution within the fields of biology, agricultural sustainability, environmental systems, and food sciences. The academic profile of Silvius Stanciu demonstrates sustained engagement in applied scientific research, particularly in environmental monitoring, agricultural development, renewable energy systems, and sustainability-oriented technological integration.[1] His publication record reflects a multidisciplinary approach connecting ecological analysis, agricultural economics, and technological innovation across regional and international contexts.[2]

Abstract

Silvius Stanciu has contributed to research concerning agricultural sustainability, environmental monitoring, food systems, and renewable energy assessment. His work incorporates data-driven methodologies, GIS-based environmental analysis, and policy-oriented agricultural studies aimed at supporting sustainable regional development.[3] The diversity of publications demonstrates engagement with interdisciplinary scientific frameworks relevant to biology and life sciences. Current studies emphasize riverbank stability, agricultural productivity, food event analysis, and climate-related agricultural trends in Romania.[4]

Keywords

Agricultural sustainability, GIS applications, renewable energy, environmental monitoring, food systems, biology and life sciences, climate analysis, technological innovation, agricultural economics, riverbank stability.

Introduction

Research within biology and life sciences increasingly integrates environmental sciences, computational analysis, and sustainability-oriented methodologies. Silvius Stanciu’s scholarly profile aligns with these contemporary academic directions through studies focused on agricultural systems, environmental risk evaluation, and regional sustainability planning.[2] His investigations into agro-food technology transfer and renewable energy uncertainties contribute to applied scientific discourse associated with climate resilience and ecological management.

Research Profile

The researcher has produced a substantial body of scholarly literature indexed through Scopus and related academic databases. His profile includes journal articles, interdisciplinary analyses, and technology-focused publications involving environmental sustainability and agricultural development. Academic output spans food systems research, renewable energy evaluation, and climate-related agricultural productivity studies.[5]

Research Contributions

  • Development of GIS-based approaches for monitoring heavy metal contamination in water systems.
  • Analysis of agricultural land-use changes affecting Danube River stability and inland navigation systems.
  • Macro-level climatic analysis of cereal productivity integrating precipitation datasets and crop statistics.
  • Research on sustainability perceptions among farm holders and agricultural stakeholders.
  • Evaluation of Romania’s renewable energy investment uncertainties using data-driven methodologies.

Publications

  • Estimating the Impact of Agricultural Land-Use–Land-Cover Change on Riverbank Stability and Critical Inland Navigation Areas of the Danube River, Earth, 2026.
  • GIS Applications in Monitoring and Managing Heavy Metal Contamination of Water Resources, Applied Sciences, 2025.
  • Data–driven analysis of Romania’s renewable energy landscape and investment uncertainties, Heliyon, 2024.

Research Impact

The research impact associated with Silvius Stanciu is reflected through interdisciplinary citation activity and publication diversity across sustainability, environmental management, and food systems studies. His research provides analytical frameworks applicable to policy development, agricultural modernization, and environmental protection strategies. The integration of technological tools such as GIS and climate datasets further strengthens the applied significance of his scientific contributions.[6]

Award Suitability

The Innovative Research Award is suitable for recognizing contributions that integrate scientific innovation with practical societal relevance. Silvius Stanciu’s work demonstrates interdisciplinary engagement connecting agricultural systems, ecological sustainability, and technological analysis. The consistent publication activity and measurable scholarly metrics support recognition within the framework of international innovation-oriented academic awards.[1]

Conclusion

Silvius Stanciu’s academic record reflects sustained participation in multidisciplinary scientific research addressing environmental sustainability, agricultural resilience, and technological advancement. His publication profile, citation performance, and ongoing research activities support recognition through the Innovative Research Award within the Global Innovation Technologist Awards framework.

References

  1. Elsevier. (n.d.). Scopus author details: Silvius Stanciu, Author ID 57202534648. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57202534648
  2. Heliyon. (2024). Data–driven analysis of Romania’s renewable energy landscape and investment uncertainties.
    https://doi.org/10.1016/j.heliyon.2024.e27334
  3. Applied Sciences. (2025). GIS Applications in Monitoring and Managing Heavy Metal Contamination of Water Resources.
    https://doi.org/10.3390/app151910332
  4. Earth. (2026). Estimating the Impact of Agricultural Land-Use–Land-Cover Change on Riverbank Stability and Critical Inland Navigation Areas of the Danube River.
    https://doi.org/10.3390/earth7030085
  5. Romanian Agricultural Research. (2026). Climatic Drivers of Cereal Productivity in Romania (1997-2024): a Macro-Level Analysis Integrating Era5 Precipitation Data and National Crop Statistics.
    https://doi.org/10.59665/rar4329
  6. Frontiers in Sustainable Food Systems. (2025). Food events from the perspective of visitors and vendors. Case study: the “Iasul în Bucate” fair, Romania.
    https://doi.org/10.3389/FSUFS.2025.1638523

Bruce Liang | Biology and Life Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Bruce Liang
University of Connecticut Health Center, United States
Bruce Liang
Affiliation University of Connecticut Health Center
Country United States
Scopus ID 7202071205
Documents 115
Citations 5,181
h-index 42
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards

The Innovative Research Award recognizes distinguished scholarly contributions and sustained scientific advancement within the field of Biology and Life Sciences. Bruce Liang of the University of Connecticut Health Center has established a notable academic profile through extensive research output, interdisciplinary biomedical investigations, and influential publications focused on cardiovascular biology, ischemic injury, receptor pharmacology, and translational medicine.[1] His body of work reflects ongoing engagement with contemporary biomedical challenges and emerging therapeutic methodologies relevant to modern clinical research.[2]

Abstract

Bruce Liang has contributed extensively to biomedical and translational research through investigations involving cardiovascular disease mechanisms, ischemic stroke biology, receptor-mediated signaling, and molecular therapeutics.[1] His publication record demonstrates a multidisciplinary approach integrating molecular biology, pharmacology, artificial intelligence applications in healthcare, and experimental cardiovascular medicine.[3] With 115 indexed scholarly documents and more than 5,181 citations recorded in Scopus, Liang’s research profile reflects sustained academic engagement and measurable scientific influence within the biomedical sciences.[1]

Keywords

Cardiovascular biology; ischemic stroke; receptor pharmacology; translational medicine; molecular therapeutics; purinergic signaling; biomedical innovation; multi-omics; artificial intelligence in medicine; targeted drug delivery; cardiovascular disease biomarkers; Biology and Life Sciences.

Introduction

Contemporary biomedical research increasingly relies on interdisciplinary methodologies capable of bridging molecular science, clinical application, and computational analysis. Bruce Liang has participated in this evolving landscape through contributions to cardiovascular and neurological research, particularly in the study of ischemia, receptor signaling pathways, inflammatory regulation, and therapeutic intervention strategies.[4] His recent publications further demonstrate interest in artificial intelligence and multi-omics approaches for disease biomarker discovery and predictive modeling within cardiovascular medicine.[5]

The breadth of Liang’s research activities reflects a combination of experimental biology, translational pharmacology, and collaborative scientific inquiry. His citation metrics and publication volume indicate substantial academic engagement within peer-reviewed biomedical literature.[1]

Research Profile

Bruce Liang is affiliated with the University of Connecticut Health Center in Farmington, United States, where his research activities are associated with cardiovascular medicine, translational therapeutics, and molecular biology.[1] His Scopus profile records 115 scholarly documents and an h-index of 42, indicating a sustained citation presence and broad dissemination of his scientific work.[1]

His research output spans several interconnected biomedical domains, including:

  • Cardiovascular disease mechanisms and molecular signaling pathways.
  • Ischemic stroke pathophysiology and neurovascular regulation.
  • AI and machine learning applications for biomarker discovery.

Research Contributions

Liang’s recent scientific contributions include investigations into P2X4 receptor signaling and ischemia/reperfusion injury in murine models.[6] His work has examined molecular mechanisms associated with cardiovascular dysfunction, inflammatory signaling, and neurovascular injury progression.[7]

A significant aspect of his recent scholarship involves the integration of multimodal artificial intelligence and machine learning methodologies for identifying novel cardiovascular disease biomarkers using multi-omics datasets.[5] These investigations contribute to ongoing efforts toward precision medicine and predictive diagnostics in clinical healthcare systems.

Publications

Selected recent publications associated with Bruce Liang include the following peer-reviewed articles:

  1. Novel P2X4 Receptor Antagonist MRS4719 Improves Ischemia/Reperfusion Injury in Mice, Medicinal Chemistry Research, 2026.
  2. TRPM2 Overactivation Drives Hyperlipidemia-Induced Dysfunction of Myeloid Cells and Neurovascular Units, Cell Reports Medicine, 2025.
  3. Multimodal AI/ML for Discovering Novel Biomarkers and Predicting Disease Using Multi-Omics Profiles of Patients with Cardiovascular Diseases, Scientific Reports, 2024.
  4. Revealing the Novel Role of Purinergic Receptor P2X4 in Phagocytic Uptake After Ischemic Stroke, Journal of the American Heart Association, 2024.
  5. Fluorescent Liposomal Nanocarriers for Targeted Drug Delivery in Ischemic Stroke Therapy, Biomaterials Science, 2023.

Research Impact

The citation record associated with Liang’s research profile indicates broad academic visibility within biomedical and translational science literature.[1] His work contributes to ongoing scientific discussions concerning cardiovascular pathology, neurovascular injury, receptor signaling, and precision medicine approaches.[5]

The interdisciplinary nature of his publications demonstrates collaboration across molecular biology, pharmacology, computational analysis, and clinical medicine. This breadth of scholarship is relevant to both laboratory-based investigations and translational healthcare research initiatives.[3]

Award Suitability

Bruce Liang’s research profile aligns with the objectives of the Global Innovation Technologist Awards through sustained scientific productivity, interdisciplinary biomedical investigation, and contributions to translational healthcare research.[1] His publication history demonstrates continued engagement with emerging scientific methodologies including multi-omics analytics, artificial intelligence-assisted disease modeling, and receptor-targeted therapeutics.[5]

The combination of citation influence, peer-reviewed scholarship, and translational research applications supports the relevance of his academic profile for recognition within innovation-oriented scientific award programs.[2]

Conclusion

Bruce Liang has developed an established research portfolio within Biology and Life Sciences through extensive scholarly publication, interdisciplinary biomedical collaboration, and investigations into cardiovascular and neurovascular disease mechanisms. His work reflects sustained participation in translational medicine, receptor biology, and computational healthcare research. The documented citation impact and continued publication activity indicate ongoing scientific engagement relevant to modern biomedical innovation and academic recognition initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Bruce Tsan Tang Liang, Author ID 7202071205. Scopus.
    www.scopus.com/authid/detail.uri?authorId=7202071205
  2. Global Innovation Technologist Awards. (2026). Award recognition and innovation excellence overview.
    innovationtechnologist.com
  3. Scientific Reports. (2024). Multimodal AI/ML for discovering novel biomarkers and predicting disease using multi-omics profiles of patients with cardiovascular diseases.
  4. Journal of the American Heart Association. (2024). Revealing the Novel Role of Purinergic Receptor P2X4 in Phagocytic Uptake After Ischemic Stroke.
  5. Nature Portfolio. (2024). Artificial intelligence and multi-omics approaches in cardiovascular disease prediction.
  6. Medicinal Chemistry Research. (2026). Novel P2X4 Receptor Antagonist MRS4719 Improves Ischemia/Reperfusion Injury in Mice.
  7. Cell Reports Medicine. (2025). TRPM2 Overactivation Drives Hyperlipidemia-Induced Dysfunction of Myeloid Cells and Neurovascular Units.

Shuai Li | Biology and Life Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Shuai Li
Regeneron, United States
Shuai Li
Affiliation Regeneron
Country United States
Scopus ID 60597499200
Documents 6
Citations 221
h-index 4
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-1537-3956

The Innovative Research Award recognizes the scholarly and scientific contributions of Shuai Li, a researcher associated with Regeneron and previously affiliated with Duke University. Li has contributed to interdisciplinary research spanning synthetic biology, metabolic engineering, supramolecular chemistry, and automated bioprocess technologies. The research portfolio demonstrates a combination of experimental innovation, engineering methodology, and translational biological applications within the broader field of biology and life sciences.[1]

Abstract

Shuai Li has developed a multidisciplinary academic profile integrating biological engineering, synthetic biology, supramolecular chemistry, and automation systems for laboratory applications. Published works include contributions to metabolic engineering in Escherichia coli, chiral molecular assemblies, CRISPR-associated biological systems, and open-source laboratory automation. The body of work reflects ongoing efforts to optimize biological production systems, enhance molecular recognition strategies, and improve accessibility to bioprocess instrumentation.[2][3]

Keywords

Synthetic Biology; Metabolic Engineering; Bioprocess Automation; Supramolecular Chemistry; CRISPR Systems; NADPH Flux; Chiroptical Switches; Biological Engineering; Automated Sampling Systems; Life Sciences Research.

Introduction

Contemporary life sciences research increasingly depends upon interdisciplinary approaches that integrate chemistry, engineering, automation, and computationally informed biological experimentation. Shuai Li’s scholarly contributions reflect this evolving research landscape through work involving engineered microbial systems, supramolecular interfaces, and laboratory automation platforms.[4]

Li completed academic training at Shandong University and the Institute of Chemistry of the Chinese Academy of Sciences before continuing research activities at Duke University. These educational and research experiences contributed to a broad methodological background that spans chemical sciences and biotechnology-oriented engineering disciplines.[1]

Research Profile

The Scopus author profile associated with Shuai Li reports 221 citations across multiple indexed documents and an h-index of 4, indicating measurable academic engagement and scholarly visibility within biotechnology and chemistry-related research communities.[1]

Research topics explored by Li include metabolic pathway optimization, enzyme regulation, supramolecular assembly, CRISPR/Cas systems, and automated sampling technologies for bioreactors. Publications demonstrate collaborations across academic laboratories and interdisciplinary scientific environments.[5]

  • Research specialization in synthetic biology and metabolic engineering.
  • Contributions to supramolecular and chiral chemistry methodologies.
  • Development of low-cost automated laboratory technologies.

Research Contributions

Among Li’s notable contributions is the development of the BioSamplr, an open-source automated sampling system designed for bioreactors. The platform aimed to provide a lower-cost alternative for laboratory sampling automation, thereby increasing accessibility for smaller research laboratories and educational institutions.[2]

Li also contributed to research focused on improving NADPH flux and xylitol biosynthesis in engineered E. coli systems through dynamic regulatory control strategies. This work addressed feedback regulation mechanisms and metabolic optimization relevant to industrial biotechnology applications.[3]

Additional studies investigated CRISPR-associated endonuclease complexes and their effects on self-targeting spacer stability. These findings contributed to understanding microbial genome regulation and CRISPR system functionality.[6]

In the field of supramolecular chemistry, Li co-authored studies examining chiroptical switches, chiral metallogels, and self-assembled polydiacetylene systems for enantioselective recognition. These works demonstrated applications of molecular self-assembly and chirality transfer in advanced chemical systems.[7][8]

Publications

  1. BioSamplr: An open source, low cost automated sampling system for bioreactors — HardwareX (2021).
  2. Dynamic control over feedback regulatory mechanisms improves NADPH flux and xylitol biosynthesis in engineered E. coli — Metabolic Engineering (2021).
  3. Escherichia coli Cas1/2 Endonuclease Complex Modifies Self-Targeting CRISPR/Cascade Spacers Reducing Silencing Guide Stability — ACS Synthetic Biology (2020).
  4. Supramolecular chiroptical switches — Chemical Society Reviews (2020).
  5. Self-Assembled Polydiacetylene Vesicle and Helix with Chiral Interface for Visualized Enantioselective Recognition of Sulfinamide — ACS Applied Materials & Interfaces (2017).

Research Impact

The academic impact of Li’s work is reflected through citations, interdisciplinary collaborations, and publication in peer-reviewed journals covering biotechnology, synthetic biology, materials science, and supramolecular chemistry. Research outputs have relevance for both academic investigation and industrial biotechnology applications.[3][7]

The integration of engineering principles with biological systems research has contributed to emerging methodologies in automated experimentation and metabolic pathway optimization. Such interdisciplinary work supports broader scientific efforts aimed at improving efficiency, reproducibility, and accessibility in laboratory research environments.[2]

Award Suitability

Shuai Li’s multidisciplinary research background aligns with the objectives of the Global Innovation Technologist Awards, which recognize scientific and technological advancements with measurable academic and practical significance. Contributions spanning metabolic engineering, CRISPR research, supramolecular chemistry, and open-source automation technologies demonstrate consistent engagement with innovation-oriented scientific inquiry.[1]

The combination of peer-reviewed publications, measurable citation performance, and interdisciplinary technical expertise supports recognition within the field of biology and life sciences. Li’s work illustrates the integration of engineering design principles with biological and chemical sciences to address contemporary research challenges.[4]

Conclusion

The scholarly profile of Shuai Li reflects interdisciplinary scientific engagement across synthetic biology, supramolecular chemistry, and laboratory engineering technologies. Through publications in recognized journals and contributions to biological automation systems, Li has participated in research initiatives with relevance to modern biotechnology and life sciences. The body of work demonstrates methodological diversity, collaborative scientific activity, and continuing participation in innovation-oriented academic research.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Shuai Li, Author ID 60597499200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60597499200
  2. Li, S. et al. (2021). BioSamplr: An open source, low cost automated sampling system for bioreactors. HardwareX.
    https://doi.org/10.1016/j.ohx.2021.e00177
  3. Li, S. et al. (2021). Dynamic control over feedback regulatory mechanisms improves NADPH flux and xylitol biosynthesis in engineered E. coli. Metabolic Engineering.
    https://doi.org/10.1016/j.ymben.2021.01.005
  4. ORCID. (n.d.). Shuai Li ORCID profile and educational background.
    https://orcid.org/0000-0002-1537-3956
  5. Crossref Metadata Search. (n.d.). Publication metadata associated with Shuai Li.
  6. Li, S. et al. (2020). Escherichia coli Cas1/2 Endonuclease Complex Modifies Self-Targeting CRISPR/Cascade Spacers Reducing Silencing Guide Stability. ACS Synthetic Biology.
    https://doi.org/10.1021/acssynbio.0c00398
  7. Li, S. et al. (2020). Supramolecular chiroptical switches. Chemical Society Reviews.
    https://doi.org/10.1039/d0cs00191k
  8. Li, S. et al. (2017). Alanine-Based Chiral Metallogels via Supramolecular Coordination Complex Platforms: Metallogelation Induced Chirality Transfer. Journal of the American Chemical Society.
    https://doi.org/10.1021/jacs.7b10769

Supriyo Chakraborty | Biotechnology | Research Excellence Award

Published on by Innovation Technologist

Dr. Supriyo Chakraborty | Biotechnology | Research Excellence Award

Professor at Assam University | India

Dr. Supriyo Chakraborty is a distinguished biotechnology researcher and academic leader whose work spans plant genetics, molecular biology, bioinformatics, and population genetics. Renowned for his impactful contributions, he has authored a substantial body of research, reflected in 4911 citations (3972 since 2020), an h-index of 29 (24 since 2020), and an i10-index of 80 (54 since 2020). His research advances codon usage bias analysis, gene expression prediction, RNA virus genomics, and computational tools for genetic and peptide property analysis. He has developed multiple awarded software innovations that enhance genomic interpretation and statistical genetics, widely used across plant, animal, and microbial systems. His notable work includes microRNA-based viral gene silencing models, codon usage and RNA editing studies in bat-borne viruses, and gene regulation mechanisms in neurobiological conditions. His contributions to QTL mapping in rice, maize, and Drosophila have supported crop improvement and advanced quantitative genetics. He has also generated important insights into human population genetics through studies on ABO and Rh gene frequencies and genetic distance estimation. As a professor of biotechnology, he has mentored numerous doctoral scholars and strengthened research and teaching in genetics, molecular biology, and plant biotechnology. His scholarly books, book chapters, popular articles, and extensive participation in national and international scientific programs reflect his commitment to advancing scientific knowledge. Dr. Chakraborty’s multifaceted research portfolio and lasting contributions place him among the leading figures in contemporary biotechnology and genetic research.

Profile: Google Scholar

Featured Publications

Malakar, A. K., Choudhury, D., Halder, B., Paul, P., Uddin, A., & Chakraborty, S. (2019). A review on coronary artery disease, its risk factors, and therapeutics. Journal of Cellular Physiology, 234(10), 16812–16823.

Paul, P., Chakraborty, A., Sarkar, D., Langthasa, M., Rahman, M., Bari, M., & Chakraborty, S. (2018). Interplay between miRNAs and human diseases. Journal of Cellular Physiology, 233(3), 2007–2018.

Khawbung, J. L., Nath, D., & Chakraborty, S. (2021). Drug resistant Tuberculosis: A review. Comparative Immunology, Microbiology and Infectious Diseases, 74, 101574.

Deb, B., Uddin, A., & Chakraborty, S. (2018). miRNAs and ovarian cancer: An overview. Journal of Cellular Physiology, 233(5), 3846–3854.

Barman, A., Deb, B., & Chakraborty, S. (2020). A glance at genome editing with CRISPR Cas9 technology. Current Genetics, 66, 447–462.

Anna Patricya Florentino | Biotechnological Applications | Best Researcher Award

Published on by Innovation Technologist

Dr. Anna Patricya Florentino | Biotechnological Applications | Best Researcher Award

Field Application Scientist at Thermo Fisher Scientific, Netherlands

Anna Patrícya Florentino is a dynamic and self-motivated microbiologist with a strong international background in bioprocess engineering, molecular biology, and chromatography-based analytical techniques. With over 15 years of experience across academia and industry, she has successfully led R&D projects in pharmaceutical, environmental, and biotechnology sectors. She has held research and teaching positions in leading institutions in Brazil, Ireland, Canada, and the Netherlands, and currently works at Thermo Fisher Scientific as a researcher and training specialist. Anna is skilled in science communication, technical training, and cross-functional collaboration.

Publication Profile 

Orcid

Google Scholar

Educational Background 🎓

  • Ph.D. in Microbiology, Wageningen University, The Netherlands (2017)
    Research: Physiology and Application of Sulfur-Reducing Microorganisms from Acidic Environments

  • M.Sc. in Civil and Environmental Engineering, Federal University of Ceará, Brazil (2013)
    Research: Pretreatment Methods for Lipid Extraction from Mixed Microalgae

  • B.Sc. in Biological Sciences, Ceará State University, Brazil (2007)
    Research: Immunological Markers for Viral Hepatitis

Professional Experience 💼

Researcher

Thermo Fisher Scientific, Breda, The Netherlands (10/2023 – Present)

  • Provides technical training and scientific support to customers

  • Specializes in chromatography, troubleshooting, and method development

  • Supports cross-functional marketing and application science teams

  • Delivers scientific presentations and customer-oriented solutions

Researcher / Lecturer

Wageningen University, Wageningen, The Netherlands (11/2020 – 09/2023)

  • Led projects in bioreactor design and sulfur compound analysis

  • Taught undergraduate and graduate microbiology courses

  • Supervised multiple MSc and BSc theses

Molecular Biologist

Oswaldo Cruz Foundation, Brazil (07/2020 – 11/2020)

Researcher / Lecturer

National University of Ireland, Galway, Ireland (09/2018 – 11/2019)

  • Managed ion chromatography lab and developed analytical methods

  • Supervised PhD students and lectured on scientific communication

Researcher

University of Alberta, Edmonton, Canada (07/2017 – 08/2018)

  • Bioreactor-based process development and microbial physiology research

  • Supervised PhD students and participated in international conferences

Young Talented Researcher

São Paulo State University, Brazil (11/2019 – 04/2020)

Clinical Analyst / Team Leader

Emílio Ribas Laboratory, Brazil (2007 – 2011)

  • Led immunological diagnostic implementation and molecular diagnostics

Research Interests 🔬

  • Bioprocess Design and Optimization

  • Sulfur-Reducing Microorganisms

  • Environmental Microbiology and Biotechnology

  • Chromatographic Method Development (IC/LC/GC)

  • Science Communication and Technical Training

  • Applied Microbiology and Analytical Chemistry

Awards and Honors🏆✨

  • Young Talented Researcher Grant, CAPES, Brazil

  • FEMS Young Scientist Meeting Grant

  • Ph.D. Research Grant, CNPq, Brazil

Conferences & Presentations🎤

A complete list can be provided upon request. Selected presentations include:

  • 13th International Congress on Extremophiles, Greece (2022)

  • 4th International Workshop on Microenergy, Denmark (2022)

  • 13th IWA Conference on Wastewater Ponds and Algal Technologies, Australia (2022)

Conclusion🌟

Anna Patrícya Florentino is a highly accomplished and globally experienced microbiologist and bioprocess specialist. She brings a rare combination of scientific depth, analytical skills, and communication expertise, making her a valuable asset in both academic and industrial R&D settings. Her work demonstrates a strong commitment to innovation in microbial biotechnology and a passion for knowledge transfer and training.

Publications 📚

📄 Orange peels bioashes from thermal treatment for adsorption of methyl orange: Experimental investigation and Life Cycle Assessment
🗞 Next Research | 📅 2025-09
🔗 DOI: 10.1016/j.nexres.2025.100419
👩‍🔬 Authors: Pedro Floriano Neto, Pedro Augusto Bertucci Lima, Ana Mariele Domingues, Anna Patrícya Florentino, Kleper de Oliveira Rocha
🧪 Focus: Waste valorization, adsorption, LCA

🦠 Synergistic nutrient removal by native microalgae-bacteria consortium: key parameter evaluation
🗞 Revista Brasileira de Ciências Ambientais | 📅 2024-10-17
🔗 DOI: 10.5327/Z2176-94781962
👩‍🔬 Authors: Thalita Lacerda dos Santos, Felipe Teles Barbosa, Anna Patrícya Florentino, Gustavo Henrique Ribeiro da Silva
🌱 Focus: Microalgae-bacteria systems, nutrient removal

🧫 Long Chain Fatty Acid Degradation Coupled to Biological Sulfidogenesis: A Prospect for Enhanced Metal Recovery
🗞 Frontiers in Bioengineering and Biotechnology | 📅 2020-10-23
🔗 DOI: 10.3389/fbioe.2020.550253
👩‍🔬 Author: Anna P. Florentino
⚙️ Focus: LCFA degradation, sulfidogenesis, metal recovery

💧 Importance of controlling phosphate concentration in nitritation–anammox reactor operation
🗞 Environmental Science: Water Research & Technology | 📅 2019
🔗 DOI: 10.1039/c9ew00203k
👩‍🔬 Author: Anna P. Florentino
🧪 Focus: Anammox process, nutrient control

⚡ Overcoming ammonia inhibition in anaerobic blackwater treatment with granular activated carbon: the role of electroactive microorganisms
🗞 Environmental Science: Water Research & Technology | 📅 2019
🔗 DOI: 10.1039/C8EW00599K
👩‍🔬 Authors: Anna Patrícya Florentino, Ahmed Sharaf, Lei Zhang, Yang Liu
🌊 Focus: Electroactive microbes, GAC, inhibition

🍽️ Co-digestion of blackwater with kitchen organic waste: Effects of mixing ratios and insights into microbial community
🗞 Journal of Cleaner Production | 📅 2019-11
🔗 DOI: 10.1016/j.jclepro.2019.117703
👩‍🔬 Author: Anna P. Florentino
🧬 Focus: Co-digestion, microbial shifts

⚫ Anaerobic digestion of blackwater assisted by granular activated carbon: From digestion inhibition to methanogenesis enhancement
🗞 Chemosphere | 📅 2019-10
🔗 DOI: 10.1016/j.chemosphere.2019.05.255
👩‍🔬 Author: Anna P. Florentino
🔥 Focus: GAC, anaerobic digestion, methane

🧲 Impact of zero valent iron on blackwater anaerobic digestion
🗞 Bioresource Technology | 📅 2019-08
🔗 DOI: 10.1016/j.biortech.2019.121351
👩‍🔬 Author: Anna P. Florentino
🧪 Focus: ZVI, anaerobic digestion

💨 Enhancing blackwater methane production by enriching hydrogenotrophic methanogens through hydrogen supplementation
🗞 Bioresource Technology | 📅 2019-04
🔗 DOI: 10.1016/j.biortech.2019.01.014
👩‍🔬 Author: Anna P. Florentino
⚡ Focus: Hydrogenotrophs, biogas enhancement

🌡️ Energy recovery from municipal wastewater: impacts of temperature and collection systems
🗞 Journal of Environmental Engineering and Science | 📅 2019-03
🔗 DOI: 10.1680/jenes.18.00017
👩‍🔬 Author: Anna P. Florentino
🔋 Focus: Wastewater energy, systems analysis

Monika Prakash | Medical Biotechnology | Best Researcher Award

Published on by Innovation Technologist

Dr. Monika Prakash | Medical Biotechnology | Best Researcher Award

Assistant Professor at Ramaiah Institute of Technology, India

Dr. Monika P is an accomplished academician and researcher with a focus on biotechnology, particularly in cell biology, nanobiotechnology, and wound healing. She is currently an Assistant Professor at the Department of Biotechnology, MS Ramaiah Institute of Technology (MSRIT), Bengaluru, where she has been teaching since November 2016. She has over 7 years of research experience and has contributed significantly to the development of novel therapeutic solutions for chronic wound healing, including research on fibroblasts, myofibroblasts, and phytocompounds.

Publication Profile 

Scopus

Educational Background 🎓

  • Ph.D. in Biotechnology, Visvesvaraya Technological University (VTU), Belagavi, 2023
  • M.Tech in Biotechnology, M.S. Ramaiah Institute of Technology (Autonomous Institute Affiliated to VTU), Bengaluru, 2014, CGPA: 9.43 (Second topper)
  • B.E. in Biotechnology, M.S. Ramaiah Institute of Technology, Bengaluru, 2011, CGPA: 8.8
  • P.U.C. (12th Standard), Maharani Lakshmi Ammanni College, Bengaluru, 2007, 83.5%
  • S.S.L.C. (10th Standard), Nirmala Rani High School, Bengaluru, 2005, 90.72%

Professional Experience 💼

  • Assistant Professor, Department of Biotechnology, MSRIT, Bengaluru, Nov 2016–Present
  • Over 8 years of teaching experience in various biotechnology-related courses
  • Guided multiple undergraduate and postgraduate student projects in fields like tissue engineering, nanobiotechnology, and chronic wound healing

Research Interests 🔬

  • Cell Biology & Cell Culture: Specialization in fibroblasts, myofibroblasts, and their role in wound healing.
  • Nanobiotechnology: Development of novel nanoformulations and scaffolds, especially for medical applications like chronic wound healing.
  • Phytocompounds: Investigating plant-based compounds for their therapeutic potential in wound healing, particularly for diabetic foot ulcers and burn wounds.
  • Chronic Wound Healing: Focus on developing low-cost, effective solutions for enhancing wound regeneration, especially for non-healing ulcers.

Awards and Honors🏆✨

  • Young Women Research Award (2025), Venus International Foundation
  • Certificate of Excellence for completing “Certified Peer Reviewer Course” from Elsevier Researcher Academy (2021)
  • Best Paper Presentation Award at the International Conference on Functional Materials, Energy, Environment, and Biomedical Applications (2022)
  • Best UG Project Award (2022) and other recognitions for mentoring top student projects
  • Best Technical Project Award from the Government of Karnataka for “Development of Nano-catechin for enhanced Bioavailability” (2014)
  • Publons Academy Graduate (2021), first from the institute

Conclusion🌟

Dr. Monika P is a dynamic academician and researcher with a passion for advancing biotechnology research, particularly in the realm of nanobiotechnology and chronic wound healing. Her strong academic background, extensive research experience, and dedication to student mentorship make her a significant contributor to the field of biotechnology. She has consistently earned recognition for her work and continues to foster innovation in her research and teaching. Through various collaborations and funded research projects, Dr. Monika P is paving the way for advancements in wound healing therapies and sustainable healthcare solutions.

Publications 📚

1. 📝 Monika, Prakash, Anushka Poola, Prithvi Prabhu, Samrat K.
“Key insights into recent advances and challenges in COVID‑19 Management”
Discover Public Health (2025) 22: 15.

2. 🧪 P. Monika, M. N. Chandraprabha, R. Hari Krishna, Vittal Maanya, C. Likhitha, N. Pooja.
“Development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti-inflammatory activity for ulcerative colitis: In vitro studies”
Hybrid Advances, 2024.

3. 🔬 Prakash Monika, Hari Krishna Rajan, Chandraprabha MN, Sakshi Shetty, Tanushka Mukherjee, S. Girish Kumar.
“Recent Developments in Green Synthesis of Hydroxyapatite Nanocomposites: Relevance to Biomedical and Environmental Applications”
Green Chemistry Letters and Reviews, 2024 (IF- 6.6, Q1)

4. 💉 Prakash, M. N. Chandraprabha, Vivek Radhakrishnan, Prathik Somayaji, Leah Sabu.
“Therapeutic potential of silkworm sericin in wound healing applications.”
Wound Repair and Regeneration, 2024 (IF-3.8, Q1, H-index – 133).

5. 🧑‍🔬 Monika Prakash, M.N. Chandraprabha, R. Hari Krishna, Harini Satish, S. Girish Kumar.
“Iron oxide nanoparticles for inflammatory bowel disease: Recent advances in diagnosis and targeted drug therapy.”
Applied Surface Science Advances. 2024, 19: 100540 (IF- 7.8, Q1).

6. 🔩 Gowda, Charishma C.; B., Lavanya; M. N., Chandra Prabha; Krishna, R. Hari; P., Monika.
“Bioceramics in Hip and Knee Implants.”
Journal of Mines, Metals & Fuels. 2023, 71 (3): 400-407. (Q4)

7. 🌿 Monika, Prakash, M. N. Chandraprabha, and K. N. Murthy.
“Catechin, epicatechin, curcumin, garlic, pomegranate peel and neem extracts of Indian origin showed enhanced anti-inflammatory potential in human primary acute and chronic wound derived fibroblasts by decreasing TGF-β and TNF-α expression.”
BMC Complementary Medicine and Therapies 23, no. 1 (2023): 1-16. (IF- 3.78, Q1)

8. 🧬 Monika, Prakash, M. N. Chandraprabha, KN Chidambara Murthy, P. Veena Waiker, and Annapoorni Rangarajan.
“Standardized ready-to-use laboratory protocol to isolate primary human wound associated fibroblasts from infected wound samples for clinical applications.”
Journal of Microbiological Methods (2023): 106712. (IF- 2.5, Q3)

9. 🧫 Monika, Prakash, M. N. Chandraprabha, and KN Chidambara Murthy.
“Gene expression studies in primary human acute and chronic wound fibroblasts treated with most popular wound healing phytoextracts.”
South African Journal of Botany 155 (2023): 205-213. (IF- 3.11, Q2).

10. 🔬 Krishna, R. Hari, M. N. Chandraprabha, Prakash Monika, Vishal Chaudhary, and C. Manjunatha.
“Biomolecule conjugated inorganic nanoparticles for biomedical applications: A review.”
Biotechnology and Genetic Engineering Reviews (2022): 1-42. (IF- 4.5, Q1).